DUL:ETR
Alnylam Pharmaceuticals
208,00 €
arrow_downward
-0,72%(-1,50) 1G
19 ott, 17:35:39 GMT+2 · EUR
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per DUL in corso…
Apertura
207,20 €
Massimo
208,40 €
Minimo
207,20 €
Cap. mercato
31,53Â Mld
Vol. medio
37,00
Volume
33,00
Max 52 sett.
417,40 €
Min 52 sett.
177,10 €
N. di dipendenti
2K
Apertura
207,20 €
Massimo
208,40 €
Minimo
207,20 €
Cap. mercato
31,53Â Mld
Vol. medio
37,00
Volume
33,00
Max 52 sett.
417,40 €
Min 52 sett.
177,10 €
N. di dipendenti
2K
Articoli giornalistici
Da fonti web e partner giornalistici
The Business Journals
·
3 giorni fa
Alnylam founder's new biotech lands $200M in upsized IPO
Profilo
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Informazioni su Alnylam Pharmaceuticals